Regen BioPharma Inc Annual Return On Equity in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Regen BioPharma Inc quarterly/annual Return On Equity history and growth rate from 2018 to 2023.
  • Regen BioPharma Inc Return On Equity for the quarter ending March 31, 2024 was 17.5 %.
  • Regen BioPharma Inc annual Return On Equity for 2023 was -23.2 %, a 144% decline from 2022.
  • Regen BioPharma Inc annual Return On Equity for 2022 was -9.5 %, a 113% decline from 2021.
  • Regen BioPharma Inc annual Return On Equity for 2021 was 74 %.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -23.2 -13.7 -144% Oct 1, 2022 Sep 30, 2023
2022 -9.5 -83.5 -113% Oct 1, 2021 Sep 30, 2022
2021 74 +113 Oct 1, 2020 Sep 30, 2021
2020 -38.6 -64.1 -252% Oct 1, 2019 Sep 30, 2020
2019 25.5 -29.9 -54% Oct 1, 2018 Sep 30, 2019
2018 55.4 Oct 1, 2017 Sep 30, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.